| PERIOD ENDING | 3-Oct-09 | 4-Jul-09 | 4-Apr-09 | 3-Jan-09 | | Total Revenue | 1,159,606 | 1,184,412 | 1,133,793 | 1,132,617 | | Cost of Revenue | 305,731 | 305,544 | 294,495 | 348,437 | | | Gross Profit | 853,875 | 878,868 | 839,298 | 784,180 | | | Operating Expenses | | Research Development | 142,224 | 143,052 | 139,351 | 138,655 | | Selling General and Administrative | 469,621 | 431,169 | 417,675 | 451,824 | | Non Recurring |
-
|
-
|
-
| 369,338 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 242,030 | 304,647 | 282,272 | (175,637) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| 658 | (361) | (9,583) | | Earnings Before Interest And Taxes | 205,866 | 305,305 | 281,911 | (185,220) | | Interest Expense | (12,570) | 5,619 | 6,951 | 7,343 | | Income Before Tax | 218,436 | 299,686 | 274,960 | (192,563) | | Income Tax Expense | 51,501 | 80,316 | 73,689 | 1,893 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 166,935 | 219,370 | 201,271 | (194,456) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 166,935 | 219,370 | 201,271 | (194,456) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $166,935 | $219,370 | $201,271 | ($194,456) |
|
0.41% Nasdaq 
Income Statement
